In June, in collaboration with Crohn’s & Colitis UK, and with support from the British Society for Gastroenterology (BSG), NASS launched the findings from their landscape review into diagnosing axial SpA in people living with inflammatory bowel disease.
As part of the NASS Act on axial SpA campaign, lunched in June 2021, we developed a 22-question survey in conjunction with key clinical advisors, Crohn’s & Colitis UK and BSG. There are two major themes emerging from this analysis to help ensure swift recognition, identification, and referral of suspected axial SpA: education and joint working with rheumatology.…
Read more of this article
NASS has set up a Peer-to-Peer Network open to any healthcare professional working in axial SpA, whether in the NHS or private practice.

Virtual Event
by Sue Brown, CEO ARMA